{"nct_id":"NCT02170727","title":"A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1","status":"COMPLETED","status_verified_date":"2020-10","start_date":"2014-06-26","start_date_type":"ACTUAL","primary_completion_date":"2015-06-12","primary_completion_date_type":"ACTUAL","completion_date":"2015-09-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}